6Finney H, Newman D J, Price CP. Adulreference ranges for serum cystatin C, ereatinine and predicted creatinine clearance [ J ]. Ann Clin Biochem ,2000,37 ( Pt1) :49-59.
7N. de F. Olivarius, A. H. Andreasen, N. Keiding, et al. Epidenfiol ogy of renal involvement in newly-diagnosed middle aged and eld erly diabetic palients[J]. Cross-sectional data from the popu'la tion-based study "Diabetes (;are in General Practice" E J]. Den mark,Diabetologia, 1993,36 (10) : 1007.
8Joint Special Committee on Renal Medicine of the Royal College of Physicians and the Renal Association, the Royal College of General Practitioners: Chronic Kidney Disease in Adults: UK Guidelines for Identification, Management and Referral London, Royal College of Physicians, 2006 : 1,5-19.
9Rigalleau V, Beauvieux MC, Le Moigne F, et al. Cystatin C im proves the diagnosis and stratification of chronic kidney disease, and the estimation of glomerular filtration rate in diabetes[J]. Di abetes and Metab,2008,34(5) :482.
10American Diabetes Association. Standards of Medical Care in Dia betes[J]. Diabetes (;are, 2001,29 $4.
1LEVEY A S,ECKARDT K U,TSUKAMOTO Y, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)[J]. Kidney Int, 2005, 67(6): 2089-2100.
